Cure call to mark AIDS anniversary

July 2011
Nursing Review (1175-2904);Jul2011, Vol. 12 Issue 3, p18
The author discusses the need to find a cure for people living with HIV. According to the author, there are compelling evidence that HIV treatment is also HIV prevention and that expanding antiretroviral therapy has preventative benefits for the entire community. As such, the International AIDS Society for which the author belongs is calling for the addition of cure to the international response to the AIDS epidemic.


Related Articles

  • Thailand to Provide Generic Medications.  // HIV Australia;Sep-Nov2004, Vol. 4 Issue 1, p35 

    Reports on the plan of Thailand to have the ability to provide generic antiretroviral medications to HIV-positive individuals within two years, according to Isaraet Gosriwatana, international sales manager for the Government Pharmaceutical Organization (GPO) in the Thai Public Health Ministry. ...

  • TREATMENT AS PREVENTION: FESTINA LENTE (HASTEN SLOWLY). Slavin, Sean // HIV Australia;Jun2012, Vol. 10 Issue 1, p6 

    The article discusses the author's views on access to antiretroviral agents as preventive treatment option for people with AIDS in Australia. He argues that medical intervention to benefit certain population might not be sufficiently effective for individual needs. The author believes that...

  • Aging and HIV/AIDS: pathogenetic role of therapeutic side effects. Torres, Rebecca A; Lewis, William // Laboratory Investigation (00236837);Feb2014, Vol. 94 Issue 2, p120 

    The intersection of aging and HIV/AIDS is a looming 'epidemic within an epidemic.' This paper reviews how HIV/AIDS and its therapy cause premature aging or contribute mechanistically to HIV-associated non-AIDS illnesses (HANA). Survival with HIV/AIDS has markedly improved by therapy combinations...

  • Beyond Core Indicators of Retention in HIV Care: Missed Clinic Visits Are Independently Associated With All-Cause Mortality. Mugavero, Michael J.; Westfall, Andrew O.; Cole, Stephen R.; Geng, Elvin H.; Crane, Heidi M.; Kitahata, Mari M.; Mathews, W. Christopher; Napravnik, Sonia; Eron, Joseph J.; Moore, Richard D.; Keruly, Jeanne C.; Mayer, Kenneth H.; Giordano, Thomas P.; Raper, James L. // Clinical Infectious Diseases;Nov2014, Vol. 59 Issue 10, p1471 

    Missed HIV care visits have independent prognostic value for clinical events beyond core indicators of retention in care. As this information is readily available and immediately actionable, missed HIV care visits should be incorporated into clinical, programmatic, and policy...

  • Study confirms effectiveness of antiretroviral drugs for HIV patients. Hagmann, Michael // Bulletin of the World Health Organization;2003, Vol. 81 Issue 12, p918 

    Reports on the effectiveness of antiretroviral drugs for HIV patients. Increase in survival rates for people with HIV-1 since the introduction of highly active antiretroviral therapy; Reduction in risk of progression to full-blown AIDS; Decline in the hazard ratio for death.

  • Current use of antiretroviral treatment. A. C. Bailey; M. Fisher // British Medical Bulletin;Sep2008, Vol. 87 Issue 1, p175 

    : Introduction Antiretroviral therapy for HIV infection has transformed it from a terminal illness to a chronic manageable condition. This review summarizes the history of the treatment and explains the current practice in the field, including uses in prevention strategies. : Sources of data...

  • Chapter 5: Treatment, care and support for people living with HIV.  // Report on the Global HIV/AIDS Epidemic: UNAIDS - 2004;1/1/2004, p99 

    Chapter 5 of the book "2004 Report on the global AIDS epidemic" is presented. It discusses the treatment and support given to people with HIV in different countries and the availability of antiretroviral therapy. It also highlights the manner of giving equitable antiretrovirals to men and women....

  • The Survival Benefits of Antiretroviral Therapy in South Africa. April, Michael D.; Wood, Robin; Berkowitz, Bethany K.; Paltiel, A. David; Anglaret, Xavier; Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P. // Journal of Infectious Diseases;Feb2014, Vol. 209 Issue 4, p491 

    Background. We sought to quantify the survival benefits attributable to antiretroviral therapy (ART) in South Africa since 2004.Methods. We used the Cost-Effectiveness of Preventing AIDS Complications–International model (CEPAC) to simulate 8 cohorts of human immunodeficiency virus...

  • Impact of Pill Sharing on Drug Resistance Due to a Wide-Scale Oral Prep Intervention in Generalized Epidemics. Dimitrov, Dobromir; Boily, Marie-Claude; Mâsse, Benoît R.; Brown, Elizabeth R. // Journal of AIDS & Clinical Research;Special2012, Vol. 3 Issue S, Special section p1 

    Background: The first antiretroviral drug (Truvada) to be used as a pre-exposure prophylaxis (PrEP) in preventing HIV transmission is about to be approved. Behavioral studies suggest that a portion of users may share anti-retroviral drugs with sex partners, family, or friends. Pill sharing will...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics